Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017

Details for Mechanism ID: 16678
Country/Region: Malawi
Year: 2016
Main Partner: Management Sciences for Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $5,752,376 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $296,250
Care: TB/HIV (HVTB) $617,500
Care: Pediatric Care and Support (PDCS) $379,560
Laboratory Infrastructure (HLAB) $50,000
Health Systems Strengthening (OHSS) $56,000
Testing: HIV Testing and Counseling (HVCT) $394,600
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,000,400
Treatment: Adult Treatment (HTXS) $2,448,366
Treatment: Pediatric Treatment (PDTX) $509,700
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HRH_PRE By Graduates: Nurses 2017 35
HRH_PRE Number of new HCW who graduated from a pre-service training institution or program as a result of PEPFAR-supported strengthening efforts, within the reporting period, by select cadre 2017 35
HRH_PRE Sum of Graduates disaggregates 2017 35
HTS_TST Age/sex: <1 2017 22,833
HTS_TST Age/sex: 1-9 2017 182,240
HTS_TST Age/sex: 10-14 Female 2017 39,692
HTS_TST Age/sex: 10-14 Male 2017 38,491
HTS_TST Age/sex: 15-19 Female 2017 33,194
HTS_TST Age/sex: 15-19 Male 2017 31,773
HTS_TST Age/sex: 20-24 Female 2017 27,886
HTS_TST Age/sex: 20-24 Male 2017 26,423
HTS_TST Age/sex: 25-49 Female 2017 80,525
HTS_TST Age/sex: 25-49 Male 2017 75,398
HTS_TST Age/sex: 50+ Female 2017 27,832
HTS_TST Age/sex: 50+ Male 2017 24,180
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 141,668
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 141,591
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 169,436
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 157,772
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 610,468
HTS_TST Service Delivery Point (Facility): Inpatient 2017 39,682
HTS_TST Service Delivery Point (Facility): Other PITC 2017 173,374
HTS_TST Service Delivery Point (Facility): Pediatric 2017 108,054
HTS_TST Service Delivery Point (Facility): PMTCT 2017 173,374
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 5,491
HTS_TST Service Delivery Point (Facility): VCT 2017 110,493
HTS_TST Sum of Age/Sex disaggregates 2017 405,394
HTS_TST Sum of Aggregated Age/Sex <15 2017 283,259
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 327,208
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 610,467
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 642
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 620
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 4,596
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 4,399
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 3,858
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 3,654
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 11,143
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 10,431
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 3,850
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 3,344
HTS_TST_POS Test Result by Age: Positive: <1 2017 366
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 2,945
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 2,292
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 2,289
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 23,449
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 21,832
PMTCT_ART Already on ART at beginning of current pregnancy 2017 7,203
PMTCT_ART New on ART 2017 6,045
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 82,315
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 3,526
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 6,567
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 177
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 95
PMTCT_EID Sum of Infant Age disaggregates 2017 10,093
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 236
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 17,387
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 27,586
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 27,580
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 9,527
PMTCT_STAT By: Known positives at entry 2017 7,647
PMTCT_STAT By: Number of new positives identified 2017 6,508
PMTCT_STAT Number of new ANC and L&D clients 2017 88,179
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 82,315
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 1,614
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 10
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 2,563
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 2,576
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 884
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: <15 2017 6
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 1,375
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 2,177
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 2,199
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 751
PMTCT_STAT Sum of Positives Status disaggregates 2017 14,155
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 251
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 18,622
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 29,545
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 29,550
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 50+ 2017 10,211
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 118
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1,996
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 64
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 986
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 3,442
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 3,165
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 116,515
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 10,522
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 95,317
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 10,675
TB_SCREENDX Screen Result: Screened Positive for TB 2017 1,596
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 96,119
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 53,104
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 6,547
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 3,619
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 159,389
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 224
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3,342
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 124
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,845
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 5,535
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 6,423
TX_CURR Age/Sex: <1 2017 2,370
TX_CURR Age/Sex: <1-9 2017 10,383
TX_CURR Age/Sex: 10-14 Female 2017 2,383
TX_CURR Age/Sex: 10-14 Male 2017 2,178
TX_CURR Age/Sex: 15-19 Female 2017 5,534
TX_CURR Age/Sex: 15-19 Male 2017 1,183
TX_CURR Age/Sex: 20-24 Female 2017 17,395
TX_CURR Age/Sex: 20-24 Male 2017 1,960
TX_CURR Age/Sex: 25-49 Female 2017 70,001
TX_CURR Age/Sex: 25-49 Male 2017 41,520
TX_CURR Age/Sex: 50+ Female 2017 5,592
TX_CURR Age/Sex: 50+ Male 2017 7,283
TX_CURR Aggregated Age/Sex: <15 Female 2017 8,914
TX_CURR Aggregated Age/Sex: <15 Male 2017 8,406
TX_CURR Aggregated Age/Sex: 15+ Female 2017 95,764
TX_CURR Aggregated Age/Sex: 15+ Male 2017 54,697
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 167,782
TX_CURR Sum of age/sex disaggregates 2017 6,717
TX_CURR Sum of Aggregated Age/Sex <15 2017 17,320
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 150,461
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 167,781
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 2,006
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 1,888
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 20,825
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 11,558
TX_NEW By Age/Sex: <1 2017 527
TX_NEW By Age/Sex: 1-9 2017 2,335
TX_NEW By Age/Sex: 10-14 Female 2017 530
TX_NEW By Age/Sex: 10-14 Male 2017 485
TX_NEW By Age/Sex: 15-19 Female 2017 1,163
TX_NEW By Age/Sex: 15-19 Male 2017 249
TX_NEW By Age/Sex: 20-24 Female 2017 3,675
TX_NEW By Age/Sex: 20-24 Male 2017 420
TX_NEW By Age/Sex: 25-49 Female 2017 14,813
TX_NEW By Age/Sex: 25-49 Male 2017 9,356
TX_NEW By Age/Sex: 50+ Female 2017 1,180
TX_NEW By Age/Sex: 50+ Male 2017 1,544
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 36,277
TX_NEW Sum of Age/Sex disaggregates 2017 33,415
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 36,277
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 58,720
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 52,851
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 2,452
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 2,309
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 30,921
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 17,169
TX_PVLS Numerator: Indication: Routine 2017 47,563
TX_PVLS Numerator: Indication: Targeted 2017 27
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 2,722
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 2,566
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 34,353
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 19,078
TX_PVLS_den Denominator: Indication: Routine 2017 52,851
TX_PVLS_den Denominator: Indication: Targeted 2017 31
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 332
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,458
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 335
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 306
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,021
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 215
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,221
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 367
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 12,954
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8,191
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,034
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,351
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,248
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,179
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 18,305
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10,054
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 30,786
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 34,180
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 376
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,625
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 378
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 340
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,139
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 245
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,575
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 404
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 14,366
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 9,090
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,150
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,494
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,384
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,307
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 20,321
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 11,169
Cross Cutting Budget Categories and Known Amounts Total: $200,000
Human Resources for Health $50,000
Renovation $150,000